DR. KENNETH KAUSHANSKY, M.D
Osteopathic Medicine in San Diego, CA

License number
California G86586
Category
Osteopathic Medicine
Type
Internal Medicine
License number
California G86586
Category
Osteopathic Medicine
Type
Hematology & Oncology
Address
Address 2
402 Dickinson St Mail Code 8811 - SUITE 380, San Diego, CA 92103
336 Pine Needles Dr, Del Mar, CA 92014
Phone
(619) 543-6170
(619) 543-3931 (Fax)
(858) 793-1479

Personal information

See more information about KENNETH KAUSHANSKY at radaris.com
Name
Address
Phone
Kenneth Kaushansky, age 70
336 Pine Needles Dr, Del Mar, CA 92014
(206) 310-4314
Kenneth Kaushansky, age 70
336 Pine Needles Dr, Del Mar, CA 92014
Kenneth Kaushansky
366 Pine Needles Dr, Del Mar, CA 92014

Organization information

See more information about KENNETH KAUSHANSKY at bizstanding.com

Kenneth Kaushansky MD

200 W Arbor Dr, San Diego, CA 92103

Industry:
Internist
Phone:
(619) 543-3000 (Phone)
Kenneth Kaushansky


Kenneth Kaushansky MD

402 Dickinson St #380, San Diego, CA 92103

Categories:
Hematology Physicians & Surgeons, Internal Medicine Physicians & Surgeons
Phone:
(619) 543-6170 (Phone)

Professional information

See more information about KENNETH KAUSHANSKY at trustoria.com
Kenneth Kaushansky Photo 1
Kenneth Kaushansky, San Diego CA

Kenneth Kaushansky, San Diego CA

Specialties:
Hematologist
Address:
402 Dickinson St, San Diego, CA 92103
200 W Arbor Dr, San Diego, CA 92103
Education:
UCLA, David Geffen School of Medicine - Doctor of Medicine*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Hematology (Internal Medicine)*


Kenneth Kaushansky Photo 2
Kenneth Kaushansky, San Diego CA

Kenneth Kaushansky, San Diego CA

Specialties:
Internal Medicine, Hematology, Hematology & Oncology, Medical Oncology
Work:
UC San Diego Health System
402 Dickinson St, San Diego, CA 92103 UC San Diego Health System
200 W Arbor Dr, San Diego, CA 92103
Education:
University of California at Los Angeles (1979)


Kenneth Kaushansky Photo 3
Dr. Kenneth Kaushansky, Stony Brook NY - MD (Doctor of Medicine)

Dr. Kenneth Kaushansky, Stony Brook NY - MD (Doctor of Medicine)

Specialties:
Hematology
Address:
Hst SUITE 4, Stony Brook 11794
UCSD MEDICAL CTR-DEPT OF MED
402 Dickinson St SUITE 380, San Diego 92103
(619) 543-6170 (Phone), (619) 543-3812 (Fax)
Certifications:
Hematology, 1984, Internal Medicine, 1982
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Hst SUITE 4, Stony Brook 11794
UCSD MEDICAL CTR-DEPT OF MED
402 Dickinson St SUITE 380, San Diego 92103
UCSD Medical Center - Hillcrest
200 West Arbor Dr, San Diego 92103
Education:
Medical School
University of California At Los Angeles
Graduated: 1979
University Wa


Kenneth Kaushansky Photo 4
Methods Of Increasing Platelet And Hematopoietic Stem Cell Production

Methods Of Increasing Platelet And Hematopoietic Stem Cell Production

US Patent:
8283313, Oct 9, 2012
Filed:
Jun 20, 2011
Appl. No.:
13/164707
Inventors:
Brian R. MacDonald - Bryn Mawr PA, US
Kenneth Kaushansky - Del Mar CA, US
Assignee:
Janssen Pharmaceutica, NV - Beerse
International Classification:
A61K 38/02
US Classification:
514 78, 424 851, 4241981, 514 79, 530300
Abstract:
A method of increasing hematopoietic stem cell production is disclosed. The method includes administering a TPO mimetic compound to a subject. Pharmaceutical compositions including a TPO mimetic compound and a pharmaceutically acceptable carrier are also disclosed.


Kenneth Kaushansky Photo 5
Methods Of Increasing Platelet And Hematopoietic Stem Cell Production

Methods Of Increasing Platelet And Hematopoietic Stem Cell Production

US Patent:
8067367, Nov 29, 2011
Filed:
Sep 18, 2003
Appl. No.:
10/667096
Inventors:
Brian R. MacDonald - Bryn Mawr PA, US
Kenneth Kaushansky - Del Mar CA, US
Assignee:
Janssen Pharmaceutica, N.V. - Beerse
International Classification:
A61K 38/02, C12N 5/00
US Classification:
514 78, 424 851, 4241981, 424 931, 424 937, 435325, 514 79, 530300
Abstract:
A method of increasing hematopoietic stem cell production is disclosed. The method includes administering a TPO mimetic compound to a subject. Pharmaceutical compositions including a TPO mimetic compound and a pharmaceutically acceptable carrier are also disclosed.